Number of shares outstanding for Catalyst Pharmaceuticals (CPRX)

Number of shares outstanding as of March 2025 : 119,892,062

According to Catalyst Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 119,892,062. At the end of 2024 the company had 119,892,062 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Catalyst Pharmaceuticals from 2004 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.11 B	12.5%
2023	0.10 B	1.9%
2022	0.10 B	1.43%
2021	0.10 B	-0.57%
2020	0.10 B	0.5%
2019	0.10 B	0.43%
2018	0.10 B	12.34%
2017	91.45 M	10.32%
2016	82.89 M	0.13%
2015	82.79 M	23.26%
2014	67.16 M	50.31%
2013	44.68 M	39.07%
2012	32.13 M	48.39%
2011	21.65 M	15.05%
2010	18.82 M	33.82%
2009	14.06 M	9.35%
2008	12.86 M	2.68%
2007	12.52 M	78.44%
2006	7.02 M	13.14%
2005	6.2 M	112.61%
2004	2.91 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
BioMarin Pharmaceutical BMRN	190,429,000	58.83%	🇺🇸 USA
Sarepta Therapeutics SRPT	96,283,000	-19.69%	🇺🇸 USA
Johnson & Johnson JNJ	2,406,922,000	1,907.57%	🇺🇸 USA
Acorda Therapeutics ACOR	1,242,000	-98.96%	🇺🇸 USA
Pfizer PFE	5,667,000,000	4,626.75%	🇺🇸 USA
Abbott Laboratories ABT	1,731,697,991	1,344.38%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions